Tectonic Therapeutic, Inc. — Director's Dealing 2018

Oct 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2018-10-08

Reporting Person: Dorton Katina (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-08	Common Stock	M	10000	$0.91	Acquired	10000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-08	Stock Option (Right to Buy)	$0.91	M	10000	Disposed	2027-07-19	Common Stock (10000)	Direct

Footnotes

F1: 25% of the shares vested on August 28, 2018, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.